Publications

March 2017
Case

From mHealth Hackathon to Reality: Diabetes Care

By: Kevin Schulman and Curry Cheek

This case explores the development of a business plan for a mobile health application for diabetes care. The case depicts a student team excited about the opportunity to improve the care of patients with diabetes by contracting an app. They go through a rigorous... View Details

Keywords: Innovation; Mobile Health Technologies; Health Care; Health Care Industry; Behavioral Economics; Applications and Software; Health Care and Treatment; Mobile and Wireless Technology; Innovation and Invention; Health Industry; Telecommunications Industry

17 Nov 2003
Research & Ideas

The Business Case for Diabetes Disease Management

end, participants agreed that while disease management is a thorny concept involving all these many constituencies, it might in some instances leave room for business potential in the form of a carve-out. A carve-out, as defined in the paper "The Business Case for... View Details

Keywords: by Martha Lagace; Health

January 2010
Teaching Note

The Joslin Diabetes Center (TN)

By: Michael E. Porter, Elizabeth O. Teisberg and Scott Wallace

Teaching Note for [710424]. View Details

Keywords: Health Care and Treatment; Groups and Teams; Medical Specialties; Programs; Opportunities; Service Delivery; Alliances; Value Creation; Health Industry; Boston

April 2009
Teaching Note

Amylin Pharmaceuticals: Diabetes and Beyond (TN)

By: Richard G. Hamermesh and Rachel Gordon

Teaching Note for [809011]. View Details

Keywords: Negotiation Deal; Product Development; Success; Commercialization; Governing Rules, Regulations, and Reforms; Resource Allocation; Pharmaceutical Industry

November 2001 (Revised September 2004)
Case

Evolution of Treatment, The: The Case of Diabetes

By: Richard M.J. Bohmer, Jeffrey D. Street and Laura Feldman

Scientific knowledge surrounding diabetes mellitus has grown over the last century to include its cause, treatment, and prevention strategies. However, the type and level of care that patients receive is suboptional. This case examines the forces in industry,... View Details

Keywords: Policy; Health Care and Treatment; Innovation and Management; Knowledge Use and Leverage; Management; Management Analysis, Tools, and Techniques; Health Industry

November 1998
Case

Wegmans Food Markets: Diabetes Counseling

By: Ray A. Goldberg, David E. Bell and Ann Leamon

Danny Wegman, president of Wegmans Food Markets, is trying to decide how to evaluate the success of a nutrition-counseling program for diabetics, and whether and how to expand the program beyond the two stores currently involved. Wegmans, with 57 stores and $2.3... View Details

Keywords: Performance Evaluation; Expansion; Programs; Human Needs; Financial Management; Health Care and Treatment; Nutrition; Consumer Behavior; Pharmaceutical Industry; Food and Beverage Industry

February 1999
Teaching Note

Wegmans Food Markets: Diabetes Counseling TN

By: David E. Bell

Teaching Note for (9-599-057). View Details

Keywords: Pharmaceutical Industry; Food and Beverage Industry

February 1996 (Revised April 2004)
Case

Eli Lilly and Company: Innovation in Diabetes Care

By: Clayton M. Christensen

Summarizes Eli Lilly's history of innovation in its business, describing how the dimensions along which innovations have been made in the industry have changed. Lilly's innovation strategy has been to pursue ever higher performance products, while others in the... View Details

Keywords: Change; Product; Service Delivery; Product Development; Innovation and Management; Innovation Strategy; Health Care and Treatment; Pharmaceutical Industry

03 Feb 2010
News

Competition Seeks Ideas About Diabetes

December 2008 (Revised October 2013)
Case

Amylin Pharmaceuticals: Diabetes and Beyond (A)

By: Richard G. Hamermesh and Rachel Gordon

Ginger Graham, CEO of Amylin Pharmaceuticals, joined the company with the expectation of taking the company's signature drug, Symlin, to market. However, unforeseen regulatory challenges have put the approval process in jeopardy. At the same time, the company has a... View Details

Keywords: Regulations; Drug Regulations; Symlin; Negotiation; Governing Rules, Regulations, and Reforms; Resource Allocation; Negotiation Deal; Product Development; Research and Development; Commercialization; Pharmaceutical Industry; United States

24 Apr 2014
News

Fighting the diabetes epidemic using mobile phones

Through Jana Care, a start-up he cofounded in Bangalore, India, Sidhant Jena (SPH 2011, MBA 2011) is building affordable diagnostics and evidence-based lifestyle coaching programs on mobile phones to make diabetes management cheaper,... View Details

January 2023
Case

Vertex and the Cure for Type 1 Diabetes

By: Amitabh Chandra, William J Anderson and Silvia Mare

Keywords: Biotechnology Industry

March 1997
Teaching Note

Eli Lilly and Company: Innovation in Diabetes Care TN

By: Clayton M. Christensen and Bret J. Baird

Teaching Note for (9-696-077). View Details

Keywords: Pharmaceutical Industry

September 2004 (Revised November 2006)
Teaching Note

Evolution of Treatment, The: The Case of Diabetes

By: Richard M.J. Bohmer

Teaching Note to (9-302-023). View Details

Keywords: Health Disorders; Nutrition

03 Feb 2010
News

Harvard-Based Crowdsource Project Seeks New Diabetes Answers - & Questions

24 Jan 2007
News

Bill Clinton, Elizabeth Teisberg to speak at the "Global Changing Diabetes Leadership Forum"

February 2019
Article

Who Benefits Most in Disease Management Programs: Improving Target Efficiency

By: Timothy Simcoe, Maryaline Catillon and Paul Gertler

Disease management programs aim to reduce cost by improving the quality of care for chronic diseases. Evidence of their effectiveness is mixed. Reducing health care spending sufficiently to cover program costs has proved particularly challenging. This study uses a... View Details

Keywords: Health Economics; Target Efficiency; Diabetes; Disease Management; Program Evaluation; Heterogeneity; Economics; Health; Quality; Health Care and Treatment; Cost Management; Health Industry

Find at Harvard

August 2024
Case

Novo Nordisk Foundation

By: Debora L. Spar and Julia Comeau

In 2024, Novo Nordisk A/S was one of the most profitable firms in the world, thanks largely to just two GLP-1-based drugs, Ozempic and Wegovy. Unusually, this incredibly profitable firm was controlled not by individual private shareholders, but by a non-profit... View Details

Keywords: Pharmaceutical Companies; Diabetes; Obesity; Foundation; Non-profit Management; Pharmaceutical Industry; Denmark; Europe